Viewing nowSitagliptin Tablets 100 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 202101003 · Approved 2021.02.02 · Insurance code 649605970
Improvement of blood sugar control in type 2 diabetes
This medication is used to improve blood sugar control in patients with type 2 diabetes in conjunction with diet and exercise. Initially, it is administered as monotherapy, and if blood sugar control is difficult with monotherapy, it can be used in combination with metformin. Additionally, this medication can be co-administered if adequate control is not achieved with sulfonylureas, metformin, thiazolidinediones, or insulin monotherapy. In cases where multiple medications are combined and blood sugar control is still insufficient, this medication can be added to enhance therapeutic efficacy. This flexible administration method helps effectively control patients' blood sugar.
This medication is administered once a day at a dose of 100 mg for monotherapy or combination therapy, with a maximum daily dose of 100 mg. This medication can be taken without regard to meals. For patients with renal impairment: 1. Mild renal impairment (eGFR ≥ 60 and < 90 mL/min/1.73 m2) does not require dose adjustment. 2. Moderate renal impairment (eGFR ≥ 45 and < 60...
This medication may cause severe allergic reactions; therefore, if symptoms such as skin rash or difficulty breathing occur after administration, discontinue use immediately and seek medical attention. This medication can cause severe inflammation of the pancreas (pancreatitis), so if symptoms such as abdominal pain, nausea, or vomiting occur during use, notify a doctor immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should also be avoided in individuals with allergies to this medication or its ingredients. Patients with decreased renal function may have delayed excretion of this medication, necessitating dose adjustment or careful use. Adverse reactions reported in clinical trials include upper respiratory infections, headaches, nasopharyngitis, diarrhea, among others. There may be an increased risk of hypoglycemia when taken with insulin or sulfonylureas. This medication has relatively few drug interactions, but caution is required when taken with cyclosporine or digoxin, and appropriate monitoring is advised. Its safety has not been established in pregnant or breastfeeding women, and its safety and efficacy in children under 18 have not been confirmed. In elderly patients, renal function decline is common, thus regular evaluation of renal function should be performed before and during administration of this medication. In case of overdose, general emergency treatments should be applied, and consideration can be given to blood dialysis since some may be removed by it if necessary. If any unusual symptoms occur during medication, such as joint pain or blisters on the skin, consult a doctor immediately for appropriate measures.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Bright brown, round, bilayered, convex film-coated tablets
28 tablets/box [(14 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.